Supriya Lifescience IPO has a new release of up to R200 crore and a commercial gift of up to R500 crore at a price range set at ₹ 265-274.
Completion of the Supriya Lifescience IPO shareholding basis is expected to take place today and if it is allocated, then a mortgage loan to withdraw the bidding account will take place on December 27. Company shares are expected to be listed next week on Tuesday, December 28 in the leading NSE and -BSE.
Supriya Lifescience Limited’s first three-day public offering (IPO) was registered 71.51 times on the last day of the stock market on Monday. The initial share sale received bids for 1,03,89,57,138 shares compared to the 1,45,28,299 shares offered. Issue price range adjusted to ₹ 265-274 per share.
The first sale of Supriya Lifescience had a new release of up to R200 crore and a promise of sale up to R500 crore. It had a price range of ₹ 265-274 per share. The company raised R315 crore for key investors before its IPO.
The matter was fully registered within a few hours of the first registration day which opened on December 16 after a strong response from store investors. The money raised from the new account will be used to finance the needs of capital expenditure, debt repayment, and general business purposes.
According to market observers, Supriya Lifescience shares a um 110 premium (GMP) in the gray market. The gray market is an illegal platform, where trading begins after the announcement of an IPO price band until it is listed.
Supriya Lifescience is one of India’s leading manufacturers and suppliers of active pharmaceutical ingredients, focusing on research and development. As of October 31, 2021, the company had a product offering of 38 APIs focused on various therapeutic components such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic.
Check Supriya Life Sciences IPO Share Allotment Status
The registrar of this IPO is Link Intime India Private Ltd, so bidders who have applied for a public issue can check their appropriate application status online at the registrar’s website.
Through Link Intime portal
- Open the official portal of Link Intime IPO Allotment page.
- Select any of the appropriate Search option from PAN, Application No. and DP Client Id.
- Select “Supriya Lifesciences Limited” option from the drop menu. It will be added in the list once, the basis of share allotment will be finalized.
- Fill the information in the next field as per the search option selected on the second step.
- Hit the search button.
- Allotment status of Supriya Lifescience IPO will open.
Through NSE Portal
- Open “Verify IPO Bid/Allotment Details” page.
- Enter Username and password correctly in fields provided.
- Click on “Login” button.
- Check for Appropriate IPO.
- Search Allotment status.
Through BSE portal
- Start by visiting the official website of BSE IPO allotment status.
- Select Equity Option.
- Select Issue name i.e., “SUPIYA LIFESCIENCE LIMITED” from the dropdown list.
- Fill IPO Application No.
- Fill PAN number.
- Click on the reCAPTCHA option and click on Search button.
- IPO details will open. Search allotment status in the details provided
Unsuccessful bidders will get refunds on December 24, and successful investors will get shares in their demat accounts on December 27. The stock is likely to debut on the BSE and National Stock Exchange on December 28.
